Advisors Asset Management, Inc. Fibrogen Inc Transaction History

Advisors Asset Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 07, 2021	SELL	$31.0 - $55.72 $245,117 - $440,578	-7,907 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$37.09 - $48.97 $3,560 - $4,701	-96 Reduced 1.2%	7,907 $293,000
Q3 2020 Nov 16, 2020	SELL	$40.47 - $45.5 $5,868 - $6,597	-145 Reduced 1.78%	8,003 $329,000
Q2 2020 Aug 12, 2020	SELL	$32.57 - $42.83 $2,377 - $3,126	-73 Reduced 0.89%	8,148 $330,000
Q1 2020 May 15, 2020	SELL	$23.3 - $45.96 $10,531 - $20,773	-452 Reduced 5.21%	8,221 $286,000

Q4 2019 Feb 14, 2020	SELL	$34.58 - $48.06 $4,287 - $5,959	-124 Reduced 1.41%	8,673 $372,000
Q3 2019 Nov 14, 2019	SELL	$36.98 - $48.45 $6,730 - $8,817	-182 Reduced 2.03%	8,797 $325,000
Q2 2019 Aug 14, 2019	BUY	$35.13 - $55.53 $102,544 - $162,092	2,919 Added 48.17%	8,979 $406,000
Q1 2019 May 15, 2019	BUY	$42.83 - $59.91 $259,549 - $363,054	6,060 New	6,060 $329,000

120

62.2M

1.54M

221K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $69.4M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisors Asset Management, Inc. with notifications on news.